Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bhowmick

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Neoplasia (New York, N.Y.)|July 19, 2003
The loss of TGF-beta signaling promotes prostate cancer metastasisWilliam H Tu, Tania Z Thomas, Naoya Masumori, et al.
The Journal of Urology|August 21, 2007
Urothelial inhibition of transforming growth factor-beta in a bladder tissue recombination modelSiam Oottamasathien, Karin Williams, Omar E Franco, et al.
The Journal of Clinical Investigation|July 27, 2018
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogrammingRajeev Mishra, Subhash Haldar, Veronica Placencio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2012
Targeted delivery of paclitaxel to EphA2-expressing cancer cellsSi Wang, Roberta Noberini, John L Stebbins, et al.
Biochemical and Biophysical Research Communications|December 30, 2006
Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urineAmosy E M'Koma, David L Blum, Jeremy L Norris, et al.
Cancer Research|January 6, 2021
A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal AdenocarcinomaSai Ma, Bo Zhou, Qian Yang, et al.
Oncogene|September 5, 2018
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent mannerManabu Kato, Veronica R Placencio-Hickok, Anisha Madhav, et al.
Cell Reports|January 20, 2023
RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancerHong-Tao Li, H Josh Jang, Krizia Rohena-Rivera, et al.
Cancer Research|August 15, 2008
The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growthRen Jie Jin, Yongsoo Lho, Linda Connelly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2022
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefitBethany N Smith, Rajeev Mishra, Sandrine Billet, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Neoplasia (New York, N.Y.)|July 19, 2003
The loss of TGF-beta signaling promotes prostate cancer metastasisWilliam H Tu, Tania Z Thomas, Naoya Masumori, et al.
The Journal of Urology|August 21, 2007
Urothelial inhibition of transforming growth factor-beta in a bladder tissue recombination modelSiam Oottamasathien, Karin Williams, Omar E Franco, et al.
The Journal of Clinical Investigation|July 27, 2018
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogrammingRajeev Mishra, Subhash Haldar, Veronica Placencio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2012
Targeted delivery of paclitaxel to EphA2-expressing cancer cellsSi Wang, Roberta Noberini, John L Stebbins, et al.
Biochemical and Biophysical Research Communications|December 30, 2006
Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urineAmosy E M'Koma, David L Blum, Jeremy L Norris, et al.
Cancer Research|January 6, 2021
A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal AdenocarcinomaSai Ma, Bo Zhou, Qian Yang, et al.
Oncogene|September 5, 2018
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent mannerManabu Kato, Veronica R Placencio-Hickok, Anisha Madhav, et al.
Cell Reports|January 20, 2023
RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancerHong-Tao Li, H Josh Jang, Krizia Rohena-Rivera, et al.
Cancer Research|August 15, 2008
The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growthRen Jie Jin, Yongsoo Lho, Linda Connelly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2022
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefitBethany N Smith, Rajeev Mishra, Sandrine Billet, et al.
Pageof 17